| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Oxford Fertility Unit, Nuffield Department of Obstetrics and Gynaecology, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom
It has been reported that preimplantation human embryos secrete HLA-G, and the levels may be predictive of their ability to implant. However, it is not known which of the membrane-bound (HLA-G 1–4) and soluble (HLA-G 5–6) alternatively spliced forms are present, nor the developmental stage at which they appear. Therefore, we have investigated HLA-G mRNA isoform expression on single embryos at the two-, four-, six-, and eight-cell, morula, and blastocyst stages. The percentage of embryos expressing each HLA-G isoform mRNA increased with developmental stage, but contrary to expectation, HLA-G5 mRNA was not detected in single two- to eight-cell embryos and was only expressed by 20% of morulae and blastocysts. Similarly, soluble HLA-G6 mRNA was not detected until the blastocyst stage and then in only one-third of embryos. In contrast, labeling with MEM G/9 Ab (specific for HLA-G1 and -G5) was observed in 15 of 20 two- to eight-cell embryos and 5 of 5 blastocysts. This disparity between mRNA and protein may be due to HLA-G protein remaining from maternal oocyte stores produced before embryonic genome activation and brings into question the measurement of soluble HLA-G for clinical evaluation of embryo quality. Although HLA-G is expressed in the preimplantation embryo, later it is primarily expressed in the invasive trophoblast of the placenta rather than the fetus. Therefore, we have investigated whether down-regulation of HLA-G first occurs in the inner cell mass (precursor fetal cells) of the blastocyst and, in support of this concept, have shown the absence HLA-G1 and -G5 protein and mRNA.
This article has been cited by other articles:
|
|
 |
|
  R. Rizzo, D. Ferrari, L. Melchiorri, M. Stignani, S. Gulinelli, O. R. Baricordi, and F. Di Virgilio Extracellular ATP Acting at the P2X7 Receptor Inhibits Secretion of Soluble HLA-G from Human Monocytes J. Immunol., October 1, 2009; 183(7): 4302 - 4311. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.J. Vercammen, A. Verloes, H. Van de Velde, and P. Haentjens Accuracy of soluble human leukocyte antigen-G for predicting pregnancy among women undergoing infertility treatment: meta-analysis Hum. Reprod. Update, May 1, 2008; 14(3): 209 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. R. Shaikly, I. E. G. Morrison, M. Taranissi, C. V. Noble, A. D. Withey, R. J. Cherry, S. M. Blois, and N. Fernandez Analysis of HLA-G in Maternal Plasma, Follicular Fluid, and Preimplantation Embryos Reveal an Asymmetric Pattern of Expression J. Immunol., March 15, 2008; 180(6): 4330 - 4337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lin, W.-H. Yan, H.-H. Xu, M.-F. Gan, J.-F. Cai, M. Zhu, and M.-Y. Zhou HLA-G expression in human ovarian carcinoma counteracts NK cell function Ann. Onc., November 1, 2007; 18(11): 1804 - 1809. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
